|
KMID : 0882420190940040330
|
|
Korean Journal of Medicine
2019 Volume.94 No. 4 p.330 ~ p.342
|
|
|
Korean Heart Rhythm Society 2019 Practical Guidelines on Antithrombotic Therapy for AF Patients Undergoing Percutaneous Coronary Intervention or Structural Heart Disease Intervention
|
|
Hwang You-Mi
Lee Ji-Hyun
Lee Ki-Hong
Lim Woo-Hyun
Shim Jae-Min
Lee Young-Soo
Park Jin-Kyu
Kim Tae-Hoon
Kim Jun
Joung Bo-Young
|
|
|
Abstract
|
|
|
|
The choice of an adequate antithrombotic regimen for atrial fibrillation patients undergoing emergent or elective percutaneous coronary intervention (PCI) should be based on the ischemic event and on the risk of bleeding. Recent randomized controlled trials have consistently demonstrated that dual antithrombotic therapeutic regimens, using non-vitamin K anticoagulants and clopidogrel, are superior to triple or dual therapy with warfarin and aspirin. This report incorporates findings of recent notable studies to provide concrete, clinically useful details and recommendations for bleeding risk assessment and optimal antithrombotic therapeutic strategies after PCI. In addition, we introduce guidelines for antithrombotic management after structural heart disease intervention.
|
|
|
KEYWORD
|
|
|
Atrial fibrillation, Anticoagulants, Guideline, Percutaneous coronary intervention
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
  
|